# Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

> **NCT00807911** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 322 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Adjuvant FL
- **DRUG:** Adjuvant FOLFOX

## Key facts

- **NCT ID:** NCT00807911
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11-01
- **Primary completion:** 2013-06-30
- **Final completion:** 2014-09-05
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807911, "Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00807911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*